MonitoringNCT07309809
Portrait Mobile Monitoring Solution V2.0 External Evaluation
A study testing Continuous Monitoring in people with Monitoring, run by GE Healthcare at 1 site in United Kingdom.
Trial summary
The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Monitoring
- What is being tested?
- Continuous Monitoring
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jul 2026to Oct 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participant is age 18 years or older (≥18 years).
- Participant must have the ability to understand and provide written informed consent.
- Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure.
- Participant must be willing and able to comply with study procedures and duration.
Who cannot join
- Known to be pregnant and/or breast feeding.
- Diagnosed with infection requiring isolation.
- Are immunocompromised.
- Have previously participated in this study (no subject may participate more than once).
- Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site
West Middlesex University Hospital
London, England, TW7 6AF
About this study
The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development, including engineering purposes as deemed appropriate by the Sponsor.
Read the detailed description
Subjects will be enrolled from a general hospital ward to receive continuous monitoring for up to 72 hours by the Portrait Mobile Monitoring Solution V2.0. After the completion of that monitoring, both the clinician and the subject will complete a feedback survey about their experience with the device. The surveys along with raw data from the device will be collected from each subject.
- Conditions
- Monitoring
- Being tested
- Continuous Monitoring
- Keywords
- Continuous Monitoring
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Continuous MonitoringDevice
Subjects will have vital signs continuously monitored for up to 72 hours with the study device
| Study group | Role | What they receive |
|---|---|---|
| Continuous Monitoring with Portrait Mobile | Experimental | Subjects will be monitored with the Portrait Mobile Monitoring Solution for up to 72 hours Receives: Device: Continuous Monitoring |
What is being measured
The primary outcome is the main question the study is designed to answer.
Collection of user feedback surveys from Clinicians
Number of clinician feedback surveys collected at the end of each shift for clinicians overseeing care of subjects receiving continuous vital signs monitoring.
Measured: Up to 72 hours
Collection of Subject Survey
Number of subject surveys collected from study participants at the end of their continuous monitoring
Measured: up to 72 hours
Secondary outcomes (1)
Collection of raw parameter data from Portrait Mobile Device
Collection of electronic waveforms and device logs from the investigational device for the entire monitoring period for each subject.
Measured: up to 72 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2025
- Study startJul 2026 (estimated)
- Primary completionOct 2026 (estimated)
- Study completionOct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MonitoringStudies of the same condition, open and under way.
- More trials run by GE HealthcareThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- GE Healthcare
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07309809
- Sponsor's protocol ID
- SA-000173
- Status last verified
- Jun 2026
- First submitted
- 3 Dec 2025
- Last updated
- 10 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No